Sign in

CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
271041563
Phone
949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
  1. 8-K Event Bylaws or fiscal year change
  2. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  3. 8-K Event Executive or director change
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. D Other Notice of Sales of Unregistered Securities
  10. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  11. 8-K Event Acquisition or sale completed · Unregistered share sale · Regulation FD disclosure
  12. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  13. 4 Insider Changes in Ownership
  14. 8-K Event Material agreement · Regulation FD disclosure
  15. 424B5 Offering Prospectus
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 4 Insider Changes in Ownership
  18. 8-K Event Material agreement · Agreement ended · New debt or obligation
  19. SC 13G Stake Amended Statement of Ownership
  20. 4 Insider Changes in Ownership

Page 23 of 35 · 688 filings